Endoscopic, histologic remission come with lower relapse risk in UC

Patients with ulcerative colitis who achieve more rigorous treatment endpoints are at lower risk for relapse than patients who only achieve clinical remission, according to study results.Siddarth Singh, MD, MS, of the division of gastroenterology at the University of California, San Diego, and colleagues wrote that clinical remission based on a Mayo endoscopic subscore (MES) of 0 or 1 and patient-reported outcomes has long served as a clinical target and primary endpoint for clinical trials in UC.“Multiple observational studies have suggested that patients with UC who achieve endoscopicRead More

Share on facebook
Share on twitter
Share on linkedin